What is "Nanotis"?

The NANOTIS Method, a next-generation digital inspection technology for infectious diseases

Available for a wide range of viruses, including COVID-19 and influenza viruses

With Saliva

Digital Infection Testing




CEO, Founder | Lisa Sakashita

M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes: Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service industry, she won MVP for top sales.

CTO | Jinsei Miyazaki

B. E., and M. E. degree from Faculty of Technology, Kyoto University.
Gust scientist of Max-Planck Institute of Bio-Physical Chemistry in 1989-1991.
1981: Joined Matsushita Electric Industries (Panasonic, as of now) and consistently kept cultivating new technology fields including immuno-chemical sensing. 2002: Established tele-healthcare based joint venture, Viterion LLC, in NY USA, and served as CTO. After return back to Japan in 2006, managed variety of medical equipments as the GM of engineering group, AA-SBU Panasonic Healthcare Co. Ltd. Transferred to Meiji Seika Pharma according to the assignment of laser technology of Photodynamic therapy against cancers in 2015.

Member of the Board | Koji Nakao

Corporate adviser of Terumo Corporation, Chairman of The Japan Federation of Medical Devices Associations, Chairman of Medical Technology Association of Japan, Director of The Japan Association for Medtech Innovation

B. L. degree from the Faculty of Law, Keio University. Nakao started his career at Terumo Corporation in 1970. Then he successively assumed the posts of Chairman & CEO of Terumo Medical Corporation (US), and Director, Vice President, and Executive Officer at Terumo Corporation. He was then elected as Chairman of the Board of the company in 2011. Since 2016, he has been the Corporate Adviser of

Member of the Board | Toshiaki Masuda

Managing Director of Nipro Corporation Medical Technology Division for Planning,Development & Marketing; Research &Development Center

Joined Nipro Corporation in 1975. Assumed his current position in 2022 after working as General Manager of Dialysis Product Sales Department, General Manager of Product Development Sales Department, Managing Director and General Manager of Research Institute.

Scientific Founder | Michika Onoda Ph.D.

Dr. Michika Onoda is a Postdoctoral Researcher at Massachusetts Institute of Technology.

He received a Ph. D. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, President’s Award). His career includes JSPS Research Fellow DC1 (2016), Visiting Researcher at University of Minnesota (2017), JSPS Superlative Postdoctoral Fellow at Nagoya University (2019 to present), and Postdoctoral Researcher at Massachusetts Institute of Technology (2019 to present).

The target of his research is to create novel functional polymeric materials, especially in the field of the polymer gel. In his career, he won more than eighteen awards at national and international conferences including the University of Tokyo President’s Award for the outstanding research about artificial amoeba utilizing polymeric fluids. In addition

Technical Advisor | Teruyuki Nagamune, Ph. D.

B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes: RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), etc.

Collaborator | Norio Omagari M.D., M.Sc., Ph.D

National Center for Global Health and Medicine
Disease Control and Prevention Center

Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke’s International Hospital as a resident and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the posts of Senior Staff and Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s Director since 2012.

Collaborator | Yoshida-Akimoto lab., the Univ. of Tokyo

Ryo Yoshida, Ph. D.

Dr. Ryo Yoshida is a full professor at The University of Tokyo. He received a Ph.D. degree in chemical engineering in 1993 from Waseda University, Japan. He was a research associate at Tokyo Women’s Medical University in 1993, a researcher at the National Institute of Materials and Chemical Research from 1994–1997, and an assistant professor at University of Tukuba from 1997–2000. In 2001, he moved to The University of Tokyo as an associate professor and became a full professor in 2012. He won the Society of Polymer Science, Japan Wiley Award in 2009.


Rised Series A funding from Niporo Corporetion

Nanotis, a UTokyo-affiliated startup, is raising funds in the series A funding round to accelerate the development of next-generation infection testing devices Nanotis Corporation (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita) , a University of Tokyo-affiliated venture engaged in the research and development of next-generation infection testing devices, has […]



Rised Series A funding from Niporo Corporetion.See more



We have raised funds in the pre-series A funding round to accelerate the development of next-generation infection testing devices. See more



We have received funding from Taisho Pharmaceutical for R&D of rapid diagnostic devices. See more



We raised ¥45M from Shizuoka Capital, Hamamatsu Photonics, and individual investors. See more



Commenced a joint research project with Yoshida-Akimoto Laboratory of the Department of Materials Engineering, Graduate School of Engineering, University of Tokyo.



Our corporate advisor Koji Nakao was appointed as the External Director of Nanotis.



Our CEO, Lisa Sakashita received the DBJ Outstanding Woman Entrepreneur Award at the "6th Woman Entrepreneurs New Business Plan Competition" hosted by Development Bank of Japan (DBJ). See more



Adopted for the 4th ASAC program, an acceleration program provided by the Tokyo Metropolitan Government and Deloitte Tomatsu Venture Support.



Reported in the April 26 issue of The Japan Times.



Reported in the February 18 issue of Weekly Toyo Keizai.



Koji Nakao, the current Corporate Advisor of Terumo Corporation and Chairman of the Japan Federation of Medical Devices Associations, was appointed as a corporate advisor of Nanotis.



Commenced a joint research project with Nagamune Laboratory of the Department of Chemistry & Biotechnology, Graduate School of Engineering, University of Tokyo.



Reported in the February issue of Monthly PROJECT DESIGN.



Reported in Nikkei Digital Health.



Received a grand prize at Grants4Apps Tokyo, an open innovation program hosted by Bayer Yakuhin. See more





Your Name*